Zydus Lifesciences

quarterly
yearly
ParticularsMar '23Jun '23Sep '23Dec '23Mar '24
Revenue2,8313,0382,6942,4783,694
Expenses2,0122,0261,7261,9042,000
EBITDA1,0241,2231,184805.901,930
EBIT700.001,1021,059678.201,791
Profit Before Tax615.001,013968.10574.301,685
Net Profit490.70780.90805.00450.401,405
Financial Ratios
Operating Profit Margin33.64%42.63%57.75%36.22%60.57%
Net Profit Margin26.73%27.21%39.27%20.24%44.50%
Earning Per Share (Diluted)4.857.717.964.4513.89
Dividends Per Share0.000.000.000.000.00
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 5.0.1
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ